THERAPEUTISCH AKTIVE PYRAZOLOPYRIMIDINDERIVATE

Patent europeic · EP2935269 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP2935269
Numer da la dumonda
EP13814962
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
20-12-2013
Publitgà
28-10-2015
Concedì
11-04-2018
Stritgà
25-07-2023
Motiv
Taxa annuala betg pajada
Classas IPC
C07D 471/04 (2006.01)
C07D 487/04 (2006.01)
A61K 31/519 (2006.01)
Prioritad
GB 201223021 20.12.2012
GB 201301935 04.02.2013
Dumonda PCT
PCT/EP2013/077846 20.12.2013
Publicaziun PCT
WO2014/096423 26.06.2014
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 25-07-2023

    Stritgà, taxa betg pajada

    Published in Swissreg on 25.07.2023

  2. 11-04-2018

    Concedì

    Published in Swissreg on 11.04.2018

Partidas

Possessur

UCB Biopharma SPRL

60 Allée de la Recherche, 1070 Brussels, BE

Katholieke Universiteit Leuven K.U. Leuven R&D

Minderbroedersstraat 8a Bus 5105, 3000 Leuven, BE

Inventur

FORD, Daniel James

Slough Berkshire SL1 3WE, GB

FRANKLIN, Richard Jeremy

Slough Berkshire SL1 3WE, GB

GHAWALKAR, Anant Ramrao

Hyderabad 500033, IN

HORSLEY, Helen Tracey

Slough Berkshire SL1 3WE, GB

HUANG, Qiuya

B-3000 Leuven, BE

REUBERSON, James Thomas

Slough Berkshire SL1 3WE, GB

VANDERHOYDONCK, Bart

B-3290 Diest, BE

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.